MGTX Meiragtx Holdings Plc

MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.

$8.96  +0.74 (9.00%)
As of 10/04/2022 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Cayman Islands
IPO date:  06/08/2018
Outstanding shares:  44,710,678
Average volume:  96,825
Market cap:   $376,016,802
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFYQFJ2
Valuation   (See tab for details)
PE ratio:   -4.23
PB ratio:   2.28
PS ratio:   17.03
Return on equity:   -53.94%
Net income %:   -393.95%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy